Fadogia agrestis safe dose: 300 mg/day
A rat study showed 300 mg/day equivalent is the dose with no toxicity for Fadogia agrestis; alternately 600 mg every other day or 3 times a week.
Snapshot · Huberman Lab
Essentials: Tools for Hormone Optimization in Males | Dr. Kyle Gillett
Explore episode
Jul 2, 2026
Where this was said
Fadogia Agrestis
At 26:23 · chapter starts 24:52
Fadogia agrestis is introduced as a plant genus that stimulates testosterone production by increasing LH release from the pituitary — acting upstream of the Leydig cells rather than mimicking LH directly. Huberman raises the toxicity concern he has heard about, and Gillett addresses it head-on: a rat study showed dose-dependent increases in the pro-inflammatory markers GGT and alkaline phosphatase at higher doses, but at the human-equivalent dose of 300 mg/day, no toxic effect was observed. He notes the important caveat that rodent toxicity doesn't always translate to humans, but recommends 300 mg/day as a conservative safe ceiling. A practical alternative he uses with his own patients is 600 mg taken three times per week (e.g., Monday, Wednesday, Friday), spreading out the exposure.
Fadogia Agrestis: LH Booster with a Safety Asterisk
Fadogia agrestis increases luteinizing hormone release from the pituitary, triggering the Leydig cells to produce more testosterone. Based on rat-to-human dose translation, 300 mg/day is the safe threshold; 600 mg three times per week is a practical alternative.
How to Start Testosterone Therapy Correctly
A physiologic starting dose is 100–120 mg/week of testosterone cypionate or enanthate, divided into every-other-day or three-times-weekly injections. Warning signs requiring close monitoring include acne, hair loss, mental status changes, lipid shifts, cardiovascular risks, fertility issues, and elevated hematocrit.
Similar snapshots
500 self-help techniques → 12 levers
Spencer Greenberg and Jeremy Stevenson analyzed almost 500 self-improvement techniques and found they all reduce to just 12 underlying psychological drivers.
Cold exposure: weak long-term evidence
Cold exposure has good short-term alertness benefits but the evidence base for long-term health benefits is much weaker than popularly believed.
20 habit techniques tested; almost none worked
In a randomized study of 20 habit-formation techniques run on hundreds of people, almost none of the techniques produced statistically meaningful results.
Tiny habit users stick to the FULL habit more
People given a tiny-habit fallback option (e.g. 10 squats instead of gym) were actually MORE successful at completing the full habit, not less.
Habit reflection = standout technique
The most effective habit-formation technique was 'habit reflection' — recalling a past successful habit, writing down what helped, then applying those lessons to a new habit.
Behavioral activation rivals CBT for depression
A study found that simply scheduling enjoyable activities was as effective as standard cognitive behavioral therapy for depression, leading to its own therapy called behavioral activation.
Worry time: batch all worries to 5 PM
The 'worry time' technique — deferring all worries to a designated time of day — helps people realize they have more control over worry than they thought and reveals it is less useful than it feels.
Sleeping faster by trying to stay awake
A study found that participants told to try to stay awake while in bed fell asleep faster than participants told to try to sleep — illustrating the paradox of direct effort.
Social anxiety eliminated in ~6 months
Spencer Greenberg reduced his severe social anxiety dramatically in roughly 6 months through a structured exposure therapy hierarchy, culminating in asking strangers for hugs.
